Can the SARS-CoV-2 Spike Protein Bind Integrins Independent of the RGD Sequence?

被引:13
作者
Beaudoin, Christopher A. [1 ]
Hamaia, Samir W. [2 ]
Huang, Christopher L. -H. [2 ,3 ]
Blundell, Tom L. [1 ]
Jackson, Antony P. [2 ]
机构
[1] Univ Cambridge, Dept Biochem, Sanger Bldg, Cambridge, England
[2] Univ Cambridge, Dept Biochem, Hopkins Bldg, Cambridge, England
[3] Univ Cambridge, Physiol Lab, Cambridge, England
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2021年 / 11卷
基金
英国惠康基金;
关键词
SARS-CoV-2; SARS-CoV-2 spike protein; integrin; integrin-binding motif; RGD; bioinformatics; STRUCTURAL BASIS; VIRUS; ALPHA-V-BETA-3; RECOGNITION; PEPTIDE; ATN-161; ENTRY; CELLS;
D O I
10.3389/fcimb.2021.765300
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The RGD motif in the Severe Acute Syndrome Coronavirus 2 (SARS-CoV-2) spike protein has been predicted to bind RGD-recognizing integrins. Recent studies have shown that the spike protein does, indeed, interact with alpha(V)beta(3) and alpha(5)beta(1) integrins, both of which bind to RGD-containing ligands. However, computational studies have suggested that binding between the spike RGD motif and integrins is not favourable, even when unfolding occurs after conformational changes induced by binding to the canonical host entry receptor, angiotensin-converting enzyme 2 (ACE2). Furthermore, non-RGD-binding integrins, such as alpha(x), have been suggested to interact with the SARS-CoV-2 spike protein. Other viral pathogens, such as rotaviruses, have been recorded to bind integrins in an RGD-independent manner to initiate host cell entry. Thus, in order to consider the potential for the SARS-CoV-2 spike protein to bind integrins independent of the RGD sequence, we investigate several factors related to the involvement of integrins in SARS-CoV-2 infection. First, we review changes in integrin expression during SARS-CoV-2 infection to identify which integrins might be of interest. Then, all known non-RGD integrin-binding motifs are collected and mapped to the spike protein receptor-binding domain and analyzed for their 3D availability. Several integrin-binding motifs are shown to exhibit high sequence similarity with solvent accessible regions of the spike receptor-binding domain. Comparisons of these motifs with other betacoronavirus spike proteins, such as SARS-CoV and RaTG13, reveal that some have recently evolved while others are more conserved throughout phylogenetically similar betacoronaviruses. Interestingly, all of the potential integrin-binding motifs, including the RGD sequence, are conserved in one of the known pangolin coronavirus strains. Of note, the most recently recorded mutations in the spike protein receptor-binding domain were found outside of the putative integrin-binding sequences, although several mutations formed inside and close to one motif, in particular, may potentially enhance binding. These data suggest that the SARS-CoV-2 spike protein may interact with integrins independent of the RGD sequence and may help further explain how SARS-CoV-2 and other viruses can evolve to bind to integrins.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Modelling of SARS-CoV-2 spike protein structures at varying pH values
    Niu, Ziyuan
    Kementzidis, Georgios
    Zhang, Peng
    Zhang, Ziji
    Essuman, Bernard
    Hasegawa, Karin
    Rafailovich, Miriam
    Simon, Marcia
    Aktas, Bertal Huseyin
    Papadopoulos, Evangelos
    Deng, Yuefan
    MOLECULAR SIMULATION, 2024, 50 (17-18) : 1540 - 1552
  • [32] Allosteric pathways of SARS and SARS-CoV-2 spike protein identified by neural relational inference
    Hu, Yao
    Li, Mingwei
    Wang, Qian
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2024, 92 (07) : 865 - 873
  • [33] SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development
    Malik, Yashpal S.
    Kumar, Prashant
    Ansari, Mohd Ikram
    Hemida, Maged G.
    El Zowalaty, Mohamed E.
    Abdel-Moneim, Ahmed S.
    Ganesh, Balasubramanian
    Salajegheh, Sina
    Natesan, Senthilkumar
    Sircar, Shubhankar
    Safdar, Muhammad
    Vinodhkumar, O. R.
    Duarte, Phelipe M.
    Patel, Shailesh K.
    Klein, Jorn
    Rahimi, Parastoo
    Dhama, Kuldeep
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [34] The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
    Dokainish, Hisham M.
    Re, Suyong
    Mori, Takaharu
    Kobayashi, Chigusa
    Jung, Jaewoon
    Sugita, Yuji
    ELIFE, 2022, 11
  • [35] Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design
    Xia, Xuhua
    VIRUSES-BASEL, 2021, 13 (01):
  • [36] Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein
    Chen, Yuliu
    Wu, Yan
    Chen, Shaoying
    Zhan, Qingping
    Wu, Dingzhou
    Yang, Chan
    He, Xiaoxue
    Qiu, Mengjie
    Zhang, Nannan
    Li, Zhaofeng
    Guo, Yunhua
    Wen, Minjun
    Lu, Lu
    Ma, Cuiqing
    Guo, Jiayin
    Xu, Wei
    Li, Xiaojuan
    Li, Lin
    Jiang, Shibo
    Pan, Xiaoyan
    Liu, Shuwen
    Tan, Suiyi
    JOURNAL OF VIROLOGY, 2022, 96 (24)
  • [37] Spike protein of SARS-CoV-2 variants: a brief review and practical implications
    Candido, Kattlyn Laryssa
    Eich, Caio Ricardo
    de Farina, Luciana Oliveira
    Kadowaki, Marina Kimiko
    da Conceicao Silva, Jose Luis
    Maller, Alexandre
    Garcia Simao, Rita de Cassia
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2022, 53 (03) : 1133 - 1157
  • [38] Functional and Structural Characterization of SARS-Cov-2 Spike Protein: An In Silico Study
    Ebrahim-Saraie, Hadi Sedigh
    Dehghani, Behzad
    Mojtahedi, Ali
    Shenagari, Mohammad
    Hasannejad-Bibalan, Meysam
    ETHIOPIAN JOURNAL OF HEALTH SCIENCES, 2021, 31 (02) : 213 - 222
  • [39] Phenothiazines Inhibit SARS-CoV-2 Entry through Targeting Spike Protein
    Liang, Taizhen
    Xiao, Shiqi
    Wu, Ziyao
    Lv, Xi
    Liu, Sen
    Hu, Meilin
    Li, Guojie
    Li, Peiwen
    Ma, Xiancai
    VIRUSES-BASEL, 2023, 15 (08):
  • [40] ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin
    Partridge, Lynda J.
    Urwin, Lucy
    Nicklin, Martin J. H.
    James, David C.
    Green, Luke R.
    Monk, Peter N.
    CELLS, 2021, 10 (06)